🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Prostate › New York › Syracuse

Qorannoo klinikaalii Kansarii Prostate Syracuse, NY keessatti

Qorannoo 9 Kansarii Prostate f Syracuse fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Associated Medical Professionals, Syracuse
Umuriin 18 fi ol · Dhiroota · Haaromfame 25-Ful-2026 · NCT07832292

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Associated Medical Professionals, Syracuse
Umuriin 18 fi ol · Dhiroota · Haaromfame 25-Ful-2026 · NCT06800313

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Namoota walitti qabaa jiraSadarkaa 3
  • Associated Medical Professionals - Urology ( Site 0081), Syracuse
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06136650

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Namoota walitti qabaa jiraSadarkaa 2/3
  • Associated Med Professionals of NY, Syracuse
Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Hematology Oncology Association of Central New York, East Syracuse · Miili 4 fagaatti
Umuriin 18 fi ol · Dhiroota · Haaromfame 22-Ful-2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Namoota walitti qabaa jiraSadarkaa 3
  • Associated Med Professionals of NY, Syracuse
Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Syracuse
Umuriin 18 fi ol · Dhiroota · Haaromfame 18-Ful-2026 · NCT06952803

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • State University of New York Upstate Medical University, Syracuse
  • Upstate Cancer Center at Hill Radiation Oncology, Syracuse
Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Ful-2026 · NCT05946213

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • State University of New York Upstate Medical University, Syracuse
  • Upstate Cancer Center Radiation Oncology at Oneida, Oneida · Miili 25 fagaatti
Umuriin 18 fi ol · Dhiroota · Haaromfame 11-Ful-2025 · NCT03678025

Qorannoo Kansarii Prostate magaalota biroo keessatti

Qorannoo biroo Syracuse keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.